Next report date
Report period
Q1 2024
EPS estimate
−0.13USD
Revenue estimate
—
−0.42USD
−29.16 MUSD
51.32 M
About Alpha Tau Medical Ltd.
Sector
Industry
CEO
Uzi Sofer
Website
Headquarters
Jerusalem
Employees (FY)
121
Founded
2015
ISIN
IL0011839383
FIGI
BBG00H5XSKB7
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DRTS is 2.50 USD — it has increased by 4.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alpha Tau Medical Ltd. stocks are traded under the ticker DRTS.
Alpha Tau Medical Ltd. is going to release the next earnings report on May 22, 2024. Keep track of upcoming events with our Earnings Calendar.
DRTS stock is 7.76% volatile and has beta coefficient of 0.58. Check out the list of the most volatile stocks — is Alpha Tau Medical Ltd. there?
DRTS earnings for the last quarter are −0.31 USD per share, whereas the estimation was −0.12 USD resulting in a −158.33% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about Alpha Tau Medical Ltd. earnings.
Yes, you can track Alpha Tau Medical Ltd. financials in yearly and quarterly reports right on TradingView.
DRTS stock has risen by 2.46% compared to the previous week, the month change is a 14.63% fall, over the last year Alpha Tau Medical Ltd. has showed a 19.87% decrease.
DRTS net income for the last quarter is −7.37 M USD, while the quarter before that showed −4.91 M USD of net income which accounts for −49.94% change. Track more Alpha Tau Medical Ltd. financial stats to get the full picture.
Today Alpha Tau Medical Ltd. has the market capitalization of 167.21 M, it has decreased by 10.75% over the last week.
No, DRTS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DRTS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alpha Tau Medical Ltd. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 30, 2024, the company has 121.00 employees. See our rating of the largest employees — is Alpha Tau Medical Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Alpha Tau Medical Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Alpha Tau Medical Ltd. stock shows the sell signal. See more of Alpha Tau Medical Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Alpha Tau Medical Ltd. future price: according to them, DRTS price has a max estimate of 13.00 USD and a min estimate of 7.00 USD. Read a more detailed Alpha Tau Medical Ltd. forecast: see what analysts think of Alpha Tau Medical Ltd. and suggest that you do with its stocks.